Investor Relations We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Neoleukin Therapeutics, Inc's financial performance into perspective. Press Releases March 8, 2023 Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition December 12, 2022 Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting November 14, 2022 Neoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Update View all press releases » Events Canaccord Genuity 42nd Annual Growth Conference August 10, 2022 at 1:00 PM EDT View Webcast Neoleukin Second Quarter 2022 Earnings Call August 9, 2022 at 4:30 PM EDT View Webcast View all events & presentations » Corporate Presentations More presentations coming soon.
March 8, 2023 Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
December 12, 2022 Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
November 14, 2022 Neoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Update